On-Demand Webcast

Share

Program Content

Activities

  • Treatment of HR+/HER2- MBC
    An Evening With Experts: Selecting and Sequencing Therapy in HR+/HER2- Metastatic Breast Cancer
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 05, 2019

    Expires: July 04, 2020

Faculty

cover img faculity

Adam M. Brufsky, MD, PhD

Associate Professor
Department of Medicine, Division of Hematology/Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Supporters

Lilly

Novartis Pharmaceuticals Corporation